Literature DB >> 35417276

SCN2A-related epilepsy of infancy with migrating focal seizures: report of a variant with apparent gain- and loss-of-function effects.

Xiao-Ru Yang1, Vamsi Krishna Murthy Ginjupalli2, Olivier Theriault2, Hugo Poulin2, Juan Pablo Appendino3, Ping Yee Billie Au1, Mohamed Chahine2,4.   

Abstract

SCN2A encodes a voltage-gated sodium channel (NaV1.2) expressed throughout the central nervous system in predominantly excitatory neurons. Pathogenic variants in SCN2A are associated with epilepsy and neurodevelopmental disorders. Genotype-phenotype correlations have been described, with loss-of-function variants typically being associated with neurodevelopmental delay and later-onset seizures, whereas gain-of-function variants more often result in early infantile-onset epilepsy. However, the true electrophysiological effects of most disease-causing SCN2A variants have yet to be characterized. We report an infant who presented with migrating focal seizures in the neonatal period. She was found to have a mosaic c.2635G>A, p.Gly879Arg variant in SCN2A. Voltage-clamp studies of the variant expressed on adult and neonatal NaV1.2 isoforms demonstrated a mixed gain and loss of function, with predominantly a loss-of-function effect with reduced cell surface expression and current density. Additional small electrophysiological alterations included a decrease in the voltage dependence of activation and an increase in the voltage dependence of inactivation. This finding of a predominantly loss-of-function effect was unexpected, as the infant's early epilepsy onset would have suggested a predominantly gain-of-function effect. This case illustrates that our understanding of genotype-phenotype correlations is still limited and highlights the complexity of the underlying electrophysiological effects of SCN2A variants.NEW & NOTEWORTHY Voltage-gated sodium channels play an important role in the central nervous system, mutations in which have been reported to be responsible for epilepsy. We report here an infant presenting with epilepsy of infancy with migrating focal seizures (EIMFS) in the neonatal period with a mosaic c.2635G>A, resulting in a p.Gly879Arg missense mutation on the SCN2A gene encoding NaV1.2 sodium channels. Biophysical characterization of this variant revealed a mixture of gain- and loss-of-function effects.

Entities:  

Keywords:  NaV1.2; SCN2A; electrophysiology; epilepsy of infancy with migrating focal seizures; sodium channel

Mesh:

Substances:

Year:  2022        PMID: 35417276      PMCID: PMC9109789          DOI: 10.1152/jn.00309.2021

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.974


  27 in total

1.  Nav1.5 channels can reach the plasma membrane through distinct N-glycosylation states.

Authors:  Aurélie Mercier; Romain Clément; Thomas Harnois; Nicolas Bourmeyster; Patrick Bois; Aurélien Chatelier
Journal:  Biochim Biophys Acta       Date:  2015-02-23

Review 2.  Genetic Testing in Pediatric Epilepsy.

Authors:  Tristan T Sands; Hyunmi Choi
Journal:  Curr Neurol Neurosci Rep       Date:  2017-05       Impact factor: 5.081

3.  Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of SCN2A epilepsy.

Authors:  Géza Berecki; Katherine B Howell; Yadeesha H Deerasooriya; Maria Roberta Cilio; Megan K Oliva; David Kaplan; Ingrid E Scheffer; Samuel F Berkovic; Steven Petrou
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

4.  Effect of phenytoin on sodium conductances in rat hippocampal CA1 pyramidal neurons.

Authors:  Zhen Zeng; Elisa L Hill-Yardin; David Williams; Terence O'Brien; Andris Serelis; Christopher R French
Journal:  J Neurophysiol       Date:  2016-08-03       Impact factor: 2.714

5.  Electrophysiological characteristics of cloned skeletal and cardiac muscle sodium channels.

Authors:  M Chahine; I Deschene; L Q Chen; R G Kallen
Journal:  Am J Physiol       Date:  1996-08

6.  Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a.

Authors:  Sarah K Bergren; Shu Chen; Andrzej Galecki; Jennifer A Kearney
Journal:  Mamm Genome       Date:  2005-10-19       Impact factor: 2.957

7.  Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.

Authors:  Sarah E Soden; Carol J Saunders; Laurel K Willig; Emily G Farrow; Laurie D Smith; Josh E Petrikin; Jean-Baptiste LePichon; Neil A Miller; Isabelle Thiffault; Darrell L Dinwiddie; Greyson Twist; Aaron Noll; Bryce A Heese; Lee Zellmer; Andrea M Atherton; Ahmed T Abdelmoity; Nicole Safina; Sarah S Nyp; Britton Zuccarelli; Ingrid A Larson; Ann Modrcin; Suzanne Herd; Mitchell Creed; Zhaohui Ye; Xuan Yuan; Robert A Brodsky; Stephen F Kingsmore
Journal:  Sci Transl Med       Date:  2014-12-03       Impact factor: 17.956

8.  Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures.

Authors:  Sunita N Misra; Kristopher M Kahlig; Alfred L George
Journal:  Epilepsia       Date:  2008-04-21       Impact factor: 5.864

9.  Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.

Authors:  Anaïs Begemann; Mario A Acuña; Markus Zweier; Marie Vincent; Katharina Steindl; Ruxandra Bachmann-Gagescu; Annette Hackenberg; Lucia Abela; Barbara Plecko; Judith Kroell-Seger; Alessandra Baumer; Kazuhiro Yamakawa; Yushi Inoue; Reza Asadollahi; Heinrich Sticht; Hanns Ulrich Zeilhofer; Anita Rauch
Journal:  Mol Med       Date:  2019-02-27       Impact factor: 6.354

10.  Alternative splicing potentiates dysfunction of early-onset epileptic encephalopathy SCN2A variants.

Authors:  Christopher H Thompson; Roy Ben-Shalom; Kevin J Bender; Alfred L George
Journal:  J Gen Physiol       Date:  2020-03-02       Impact factor: 4.086

View more
  1 in total

1.  De novo Y1460C missense variant in NaV1.1 impedes the pore region and results in epileptic encephalopathy.

Authors:  Quentin Plumereau; Aya Ebdalla; Hugo Poulin; Juan Pablo Appendino; Morris H Scantlebury; Ping Yee Billie Au; Mohamed Chahine
Journal:  Sci Rep       Date:  2022-10-13       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.